GANX - Gain Therapeutics Inc
IEX Last Trade
1.1
0.030 2.727%
Share volume: 555,763
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.07
0.03
2.80%
Summary score
23%
Profitability
25%
Dept financing
9%
Liquidity
62%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2019 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-26.24%
Return on assets
-18.16%
Return on sales
-13909.73%
Return on invested capital
248.43%
Total debt ratio
21.63%
Debt ratio change over timeo
-0.87%
Current Ratio
8.71%
Quick Ratio
8.71%
Cash Position Ratio
8.4%
Short-term ratios 31-Dec-2022 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-51.29%
Return on assets
-31.3%
Return on sales
-9477.68%
Return on invested capital
134.88%
Total debt ratio
37.17%
Debt ratio change over timeo
-0.69%
Current Ratio
3.18%
Quick Ratio
3.18%
Cash Position Ratio
2.97%
Last quarter ratios 31-Dec-2023
The data are presented for the financials results of the last quarter.
Return on equity
-37.56%
Return on assets
-23.68%
Return on sales
0%
Return on invested capital
114.67%
Total debt ratio
32.41%
Debt ratio change over time
-0.72%
Current Ratio
3.59%
Quick Ratio
3.59%
Cash Position Ratio
3.39%
Performance ratios (change over 4 years) 31-Dec-2019 - 31-Dec-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-117%
Return on assets
-110.91%
Return on sales
-5384.74%
Return on invested capital
16.73%
Total debt ratio
-86.99%
Debt ratio change over time
-0.87%
Current Ratio
2.91%
Quick Ratio
2.91%
Cash Position Ratio
2.79%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GANX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -26.24% | 10.2% | 35.82% | 7.59% |
| Return on assets | -18.16% | 2.89% | 3.31% | 5.76% |
| Return on sales | -13909.73% | 29.84% | 34.06% | 41.2% |
| Return on invested capital | 248.43% | 3.06% | 5.78% | 20.17% |
| Profitability | 25% | 38% | 61% | 57% |
| Total debt ratio | 21.63% | 91.31% | 89.91% | 26.84% |
| Debt ratio change over time | -0.87% | 295.05% | -10.03% | 1.11% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 3.18% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 3.18% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 2.97% | 0.31% | 1.72% | 2.92% |
| Liquididy | 75% | 7% | 13% | 29% |
| Short-term ratios | GANX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -51.29% | 9.95% | 27.09% | 4.01% |
| Return on assets | -31.3% | 2.47% | 2.17% | 3.36% |
| Return on sales | -9477.68% | 24.58% | 28.87% | 32.26% |
| Return on invested capital | 134.88% | 1.71% | 5.84% | 9.7% |
| Profitability | 25% | 47% | 65% | 55% |
| Total debt ratio | 37.17% | 91.02% | 92.9% | 21.89% |
| Debt ratio change over time | -0.69% | 107.3% | -84.55% | 1.71% |
| Dept financing | 10% | 49% | 25% | 6% |
| Current Ratio | 3.18% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 3.18% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 2.97% | 0.31% | 1.72% | 2.92% |
| Liquididy | 57% | 11% | 38% | 75% |